Related Experiment Video
Updated: May 8, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
There is much to be learnt about the costs of multiple sclerosis in Latin America
Marina Romano1, Gerardo Machnicki, Juan Ignacio Rojas
1Centro de Educación Médica e Investigaciones Clínicas, Norberto Quirno, Argentina.
Method:
A systematic review of the literature from 1990 to 2011 was conducted. Outcome measures included: mean cost of disease modifying therapies (DMTs), mean cost of treatment of relapses and mean cost of disease by stage stratification measured by the expanded disability status scale (EDSS).
Results:
Seven studies from three countries (Brazil, Argentina and Colombia) were included. In 2004, in Argentina, the mean cost of DMT treatment was reported to be USD 35,000 per patient treated. In Brazil, the total MS expenditure of DMTs rose from USD 14,011,700 in 2006 to USD 122,575,000 in 2009. Patient costs ranged between USD 10,543 (EDSS 8-9.5) and USD 25,713 (EDSS 3-5.5). Indirect costs markedly increased for the EDSS 8-9.5 patients.
Conclusion:
Further research assessing the economic burden of MS in LA is warranted.
Related Concept Videos
Multiple Sclerosis l: Introduction
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Satellite Stem Cells and Muscular Dystrophy
Secondary Spinal Cord Injury llI: Pathophysiology
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Spinal Cord Injury ll: Pathophysiology

